Boaz Weinstein’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.7M Buy
1,348,202
+588,696
+78% +$8.47M 0.53% 42
2026
Q1
$10.9M Buy
+759,506
New +$11.3M 0.3% 69
2025
Q2
Sell
-20,750,913
Closed -$309M 328
2025
Q1
$309M Hold
20,750,913
8.36% 3
2024
Q4
$299M Buy
20,750,913
+89,523
+0.4% +$1.39M 7% 3
2024
Q3
$327M Buy
20,661,390
+122,959
+0.6% +$1.94M 6.82% 3
2024
Q2
$315M Buy
20,538,431
+46,421
+0.2% +$704K 5.25% 4
2024
Q1
$336M Buy
20,492,010
+3,705,172
+22% +$58.4M 5.75% 4
2023
Q4
$246M Buy
16,786,838
+8,439,174
+101% +$118M 4.95% 3
2023
Q3
$120M Buy
8,347,664
+1,827,094
+28% +$28.5M 2.89% 8
2023
Q2
$107M Buy
6,520,570
+2,043,886
+46% +$33.3M 2.79% 6
2023
Q1
$74.8M Buy
4,476,684
+2,008,373
+81% +$32.3M 1.43% 8
2022
Q4
$38.1M Buy
+2,468,311
New +$38.2M 0.52% 20

Other funds holding BMEZ

Boaz Weinstein's BMEZ Position: Q2 2026 in Review

Boaz Weinstein increased its BlackRock Health Sciences Trust II (BMEZ) stake by 78% in Q2 2026, buying an estimated $8.47M and bringing the position to 1,348,202 shares worth $20.7M. The position accounts for 0.53% of the portfolio, ranked #42.

Boaz Weinstein first reported a position in BMEZ in Q4 2022 and has held it in 12 quarters since. The position peaked at $336M in Q1 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Boaz Weinstein held 1,348,202 shares of BlackRock Health Sciences Trust II worth $20.7M as of Q2 2026.
  • Boaz Weinstein bought 588,696 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $8.47M.
  • BlackRock Health Sciences Trust II made up 0.53% of Boaz Weinstein's portfolio in Q2 2026, its #42 holding.
  • Boaz Weinstein first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and has held it in 12 quarters since.
  • Boaz Weinstein's BlackRock Health Sciences Trust II position peaked at $336M in Q1 2024.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Saba Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.